High-dose intravenous immune globulin for stiff-person syndrome.

Stiff-person syndrome with amphiphysin antibodies: distinctive features of a rare disease. Neurology (2008) 2.48

Central nervous system neuronal surface antibody associated syndromes: review and guidelines for recognition. J Neurol Neurosurg Psychiatry (2012) 2.21

Glycine receptor autoimmune spectrum with stiff-man syndrome phenotype. JAMA Neurol (2013) 2.10

Recommendations for the use of albumin and immunoglobulins. Blood Transfus (2009) 1.75

Glycine receptor antibodies in PERM and related syndromes: characteristics, clinical features and outcomes. Brain (2014) 1.67

Clinical uses of intravenous immunoglobulin. Clin Exp Immunol (2005) 1.61

The role of IVIg in the treatment of patients with stiff person syndrome and other neurological diseases associated with anti-GAD antibodies. J Neurol (2005) 1.57

Intravenous immunoglobulin: an update on the clinical use and mechanisms of action. J Clin Immunol (2007) 1.57

Losing your nerves? Maybe it's the antibodies. Nat Rev Immunol (2009) 1.52

Autoimmune stiff person syndrome and related myelopathies: understanding of electrophysiological and immunological processes. Muscle Nerve (2012) 1.51

Movement disorders in paraneoplastic and autoimmune disease. Curr Opin Neurol (2011) 1.28

Cerebellar ataxia and glutamic acid decarboxylase antibodies: immunologic profile and long-term effect of immunotherapy. JAMA Neurol (2014) 1.01

Antibodies to inhibitory synaptic proteins in neurological syndromes associated with glutamic acid decarboxylase autoimmunity. PLoS One (2015) 0.96

Brain-reactive antibodies and disease. Annu Rev Immunol (2013) 0.94

Rapid and reversible responses to IVIG in autoimmune neuromuscular diseases suggest mechanisms of action involving competition with functionally important autoantibodies. J Peripher Nerv Syst (2013) 0.91

Cognitive dysfunction associated with anti-glutamic acid decarboxylase autoimmunity: a case-control study. BMC Neurol (2013) 0.89

Stiff person syndrome (SPS) complicated by respiratory failure: successful treatment with rituximab. J Neurol (2011) 0.89

Childhood stiff-person syndrome improved with rituximab. Case Rep Neurol (2012) 0.87

Mechanistic effects of IVIg in neuroinflammatory diseases: conclusions based on clinicopathologic correlations. J Clin Immunol (2014) 0.85

Long-lived plasma cells and memory B cells produce pathogenic anti-GAD65 autoantibodies in Stiff Person Syndrome. PLoS One (2010) 0.85

Recent Advances and Review on Treatment of Stiff Person Syndrome in Adults and Pediatric Patients. Cureus (2015) 0.84

Efficacy of Intravenous Immunoglobulin in Neurological Diseases. Neurotherapeutics (2016) 0.82

IVIg in other autoimmune neurological disorders: current status and future prospects. J Neurol (2008) 0.82

Role of IVIg in autoimmune, neuroinflammatory and neurodegenerative disorders of the central nervous system: present and future prospects. J Neurol (2006) 0.81

Cognitive decline in a patient with anti-glutamic acid decarboxylase autoimmunity; case report. BMC Neurol (2011) 0.80

Intravenous immunoglobulin therapy in paraneoplastic neurological syndromes. J Neurol (2006) 0.80

Rare indications of IVIG therapy in neurological diseases based on case reports and small studies. J Neurol (2006) 0.79

Immune mediated diseases and immune modulation in the neurocritical care unit. Neurotherapeutics (2012) 0.78

Intravenous immunoglobulin in neurological disorders: a mechanistic perspective. J Neurol (2005) 0.78

Stiff man syndrome: a diagnostic dilemma in a young female with diabetes mellitus and thyroiditis. Clin Med Insights Case Rep (2014) 0.76

Surviving stiff-person syndrome: a case report. J Neurol (2011) 0.76

[A low back pain revealing a stiff-man syndrome]. Pan Afr Med J (2013) 0.75

Clinical applications of immunoglobulin: update. Rev Bras Hematol Hemoter (2011) 0.75

The Production Processes and Biological Effects of Intravenous Immunoglobulin. Biomolecules (2016) 0.75

Stiff limb syndrome: a case report. Cases J (2010) 0.75

Progressive encephalomyelitis with rigidity and myoclonus (PERM): brucellosis as a possible triggering factor and long-term follow-up therapy with rituximab. Ther Adv Neurol Disord (2016) 0.75

Stiff person syndrome in South Asia. BMC Res Notes (2016) 0.75

New advances in the treatment of neurological diseases using high dose intravenous immunoglobulins. Ther Adv Neurol Disord (2008) 0.75

High-dose intravenous immune globulin for stiff-person syndrome. N Engl J Med (2002) 0.75

High-dose intravenous immune globulin for stiff-person syndrome. N Engl J Med (2002) 0.75

9 Human Immunoglobulins. Transfus Med Hemother (2009) 0.75

Evaluation of Treatment Outcomes in Patients with Stiff Person Syndrome with Rituximab vs. Standard of Care. Cureus (2017) 0.75

[Current use of immunoglobulins in neurology]. Nervenarzt (2008) 0.75

A case of stiff dog syndrome associated with anti-glutamic acid decarboxylase antibodies. J Clin Mov Disord (2017) 0.75

Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J (1998) 9.36

FcR gamma chain deletion results in pleiotrophic effector cell defects. Cell (1994) 7.66

Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities. J Biol Chem (2001) 7.03

Cooperative regulation of cell polarity and growth by Drosophila tumor suppressors. Science (2000) 6.44

KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma. Nat Med (1996) 5.96

Influenza A virus NS1 protein prevents activation of NF-kappaB and induction of alpha/beta interferon. J Virol (2000) 5.44

Cre-mediated gene deletion in the mammary gland. Nucleic Acids Res (1997) 4.89

American College of Rheumatology classification criteria for Sjögren's syndrome: a data-driven, expert consensus approach in the Sjögren's International Collaborative Clinical Alliance cohort. Arthritis Care Res (Hoboken) (2012) 4.82

Live attenuated malaria vaccine designed to protect through hepatic CD8⁺ T cell immunity. Science (2011) 4.72

A 1.5 million-base pair inversion polymorphism in families with Williams-Beuren syndrome. Nat Genet (2001) 4.58

Dicistronic targeting constructs: reporters and modifiers of mammalian gene expression. Proc Natl Acad Sci U S A (1994) 4.44

Seroepidemiology for MERS coronavirus using microneutralisation and pseudoparticle virus neutralisation assays reveal a high prevalence of antibody in dromedary camels in Egypt, June 2013. Euro Surveill (2013) 4.37

Neurotoxicity induces cleavage of p35 to p25 by calpain. Nature (2000) 4.31

The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial. Kidney Int (2011) 4.27

Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease. Nat Med (2000) 4.18

A mutation in succinate dehydrogenase cytochrome b causes oxidative stress and ageing in nematodes. Nature (1998) 4.06

15-deoxy-delta 12,14-prostaglandin J2 inhibits multiple steps in the NF-kappa B signaling pathway. Proc Natl Acad Sci U S A (2000) 3.89

Homer binds a novel proline-rich motif and links group 1 metabotropic glutamate receptors with IP3 receptors. Neuron (1998) 3.59

Assembly of the mitochondrial membrane system: sequences of yeast mitochondrial valine and an unusual threonine tRNA gene. Cell (1979) 3.39

Crystal structure and functional analysis of the HERG potassium channel N terminus: a eukaryotic PAS domain. Cell (1998) 3.22

Codon recognition rules in yeast mitochondria. Proc Natl Acad Sci U S A (1980) 3.11

Middle East Respiratory Syndrome (MERS) coronavirus seroprevalence in domestic livestock in Saudi Arabia, 2010 to 2013. Euro Surveill (2013) 2.99

Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's disease. Nature (1999) 2.97

Evidence for in vivo but not in vitro expression of a Borrelia burgdorferi outer surface protein F (OspF) homologue. Mol Microbiol (1995) 2.92

Alcohol drinking and all cancer mortality: a meta-analysis. Ann Oncol (2012) 2.83

Cloning of the cDNA for human IFN-gamma-inducing factor, expression in Escherichia coli, and studies on the biologic activities of the protein. J Immunol (1996) 2.80

Transformation of Bacillus stearothermophilus with plasmid DNA and characterization of shuttle vector plasmids between Bacillus stearothermophilus and Bacillus subtilis. J Bacteriol (1982) 2.80

PKA and MPF-activated polo-like kinase regulate anaphase-promoting complex activity and mitosis progression. Mol Cell (1998) 2.75

Identification of the paromomycin-resistance mutation in the 15 S rRNA gene of yeast mitochondria. J Biol Chem (1982) 2.70

Ribosomal protein S7 as a novel modulator of p53-MDM2 interaction: binding to MDM2, stabilization of p53 protein, and activation of p53 function. Oncogene (2007) 2.68

Interferon-gamma-inducing factor enhances T helper 1 cytokine production by stimulated human T cells: synergism with interleukin-12 for interferon-gamma production. Eur J Immunol (1996) 2.67

Caveolin-3 null mice show a loss of caveolae, changes in the microdomain distribution of the dystrophin-glycoprotein complex, and t-tubule abnormalities. J Biol Chem (2001) 2.62

Purification and characterization of the human interleukin-18 receptor. J Biol Chem (1997) 2.58

Fusion of two novel genes, RBM15 and MKL1, in the t(1;22)(p13;q13) of acute megakaryoblastic leukemia. Nat Genet (2001) 2.55

Transient gene transfer and expression of Smad7 prevents bleomycin-induced lung fibrosis in mice. J Clin Invest (1999) 2.50

Ketamine anesthesia during the first week of life can cause long-lasting cognitive deficits in rhesus monkeys. Neurotoxicol Teratol (2011) 2.41

Isolation and characterization of antibiotic resistance plasmids from thermophilic bacilli and construction of deletion plasmids. J Bacteriol (1981) 2.40

Deregulation of cell growth by the K1 gene of Kaposi's sarcoma-associated herpesvirus. Nat Med (1998) 2.38

The gut as a portal of entry for bacteremia. Role of protein malnutrition. Ann Surg (1987) 2.38

High-affinity receptor-mediated internalization and degradation of interleukin 2 in human T cells. J Exp Med (1986) 2.37

A RUNX2/PEBP2alpha A/CBFA1 mutation displaying impaired transactivation and Smad interaction in cleidocranial dysplasia. Proc Natl Acad Sci U S A (2000) 2.31

The clinical spectrum of anti-GAD antibody-positive patients with stiff-person syndrome. Neurology (2000) 2.20

A clustering approach to multireference alignment of single-particle projections in electron microscopy. J Struct Biol (2010) 2.19

CREB-binding protein sequestration by expanded polyglutamine. Hum Mol Genet (2000) 2.18

Characterization of human tracheal epithelial cells transformed by an origin-defective simian virus 40. Proc Natl Acad Sci U S A (1988) 2.15

Accessory protein facilitated CFTR-CFTR interaction, a molecular mechanism to potentiate the chloride channel activity. Cell (2000) 2.15

Borrelia burgdorferi supercoiled plasmids encode multicopy tandem open reading frames and a lipoprotein gene family. J Bacteriol (1996) 2.14

Lung cancer proliferation correlates with [F-18]fluorodeoxyglucose uptake by positron emission tomography. Clin Cancer Res (2000) 2.13

Cytoplasmic dynein function is essential in Drosophila melanogaster. Genetics (1996) 2.10

Dietetic guidelines on food and nutrition in the secondary prevention of cardiovascular disease - evidence from systematic reviews of randomized controlled trials (second update, January 2006). J Hum Nutr Diet (2006) 2.09

Use of the UGA terminator as a tryptophan codon in yeast mitochondria. Proc Natl Acad Sci U S A (1979) 2.05

Clinical studies of cefazolin in the surgical field. Antimicrob Agents Chemother (Bethesda) (1970) 2.03

Regulation of transport of the dopamine D1 receptor by a new membrane-associated ER protein. Nat Cell Biol (2001) 1.99

MicroRNA-221/222 confers breast cancer fulvestrant resistance by regulating multiple signaling pathways. Oncogene (2010) 1.97

Solution structure of the extended neuronal nitric oxide synthase PDZ domain complexed with an associated peptide. Nat Struct Biol (1999) 1.95

Colorectal carcinomas in mice lacking the catalytic subunit of PI(3)Kgamma. Nature (2000) 1.93

Conditional gene expression in secretory tissues and skin of transgenic mice using the MMTV-LTR and the tetracycline responsive system. J Cell Biochem (1995) 1.93

PR39, a peptide regulator of angiogenesis. Nat Med (2000) 1.90

Cell surface phenotypes and expression of viral antigens of various human cell lines carrying human T-cell leukemia virus. Int J Cancer (1984) 1.89

Modified sutureless sclerotomies in pars plana vitrectomy. Am J Ophthalmol (1999) 1.89

Effect of spironolactone on plasma brain natriuretic peptide and left ventricular remodeling in patients with congestive heart failure. J Am Coll Cardiol (2001) 1.87

Identification of an immunoreceptor tyrosine-based activation motif of K1 transforming protein of Kaposi's sarcoma-associated herpesvirus. Mol Cell Biol (1998) 1.84

Clinicopathological features of Churg-Strauss syndrome-associated neuropathy. Brain (1999) 1.84

Synectin, syndecan-4 cytoplasmic domain binding PDZ protein, inhibits cell migration. J Cell Physiol (2000) 1.82

Time-sensitive reversal of hyperplasia in transgenic mice expressing SV40 T antigen. Science (1996) 1.82

Molecular cloning of a thermostable neutral protease gene from Bacillus stearothermophilus in a vector plasmid and its expression in Bacillus stearothermophilus and Bacillus subtilis. J Bacteriol (1983) 1.80

Heme oxygenase-1 protects against radiocontrast-induced acute kidney injury by regulating anti-apoptotic proteins. Kidney Int (2007) 1.80

Hemorrhagic shock induces bacterial translocation from the gut. J Trauma (1988) 1.77

Wound healing is accelerated by agonists of adenosine A2 (G alpha s-linked) receptors. J Exp Med (1997) 1.75

Constitutive activation of NF-kappaB in primary adult T-cell leukemia cells. Blood (1999) 1.73

A PDZ-interacting domain in CFTR is an apical membrane polarization signal. J Clin Invest (1999) 1.73

Nanosecond dynamics of the near-infrared photoluminescence of Er-doped SiO2 sensitized with Si nanocrystals. Phys Rev Lett (2006) 1.72

Peptide binding consensus of the NHE-RF-PDZ1 domain matches the C-terminal sequence of cystic fibrosis transmembrane conductance regulator (CFTR). FEBS Lett (1998) 1.72

Minocycline reduces traumatic brain injury-mediated caspase-1 activation, tissue damage, and neurological dysfunction. Neurosurgery (2001) 1.69

Assembly of voltage-gated potassium channels. Conserved hydrophilic motifs determine subfamily-specific interactions between the alpha-subunits. J Biol Chem (1995) 1.69

PDZ domain of neuronal nitric oxide synthase recognizes novel C-terminal peptide sequences. Nat Biotechnol (1997) 1.68

High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure. J Am Coll Cardiol (2000) 1.64

Development of antisera selective for m4 and m5 muscarinic cholinergic receptors: distribution of m4 and m5 receptors in rat brain. Mol Pharmacol (1993) 1.60

Respiratory mechanics and peripheral airway inflammation and dysfunction in asthma. Clin Exp Allergy (2013) 1.59

Tumor development in the Beckwith-Wiedemann syndrome is associated with a variety of constitutional molecular 11p15 alterations including imprinting defects of KCNQ1OT1. Hum Mol Genet (2001) 1.58

Hypothalamus and amygdala response to acupuncture stimuli in Carpal Tunnel Syndrome. Pain (2007) 1.58

Structure and mechanism of monoamine oxidase. Curr Med Chem (2004) 1.58

Evaluation of angiogenesis in non-small cell lung cancer: comparison between anti-CD34 antibody and anti-CD105 antibody. Clin Cancer Res (2001) 1.55

CD8 T cell ignorance or tolerance to islet antigens depends on antigen dose. Proc Natl Acad Sci U S A (1999) 1.55

Differential stimulation of PKC phosphorylation of potassium channels by ZIP1 and ZIP2. Science (1999) 1.55

The p53--Mdm2--HAUSP complex is involved in p53 stabilization by HAUSP. Oncogene (2007) 1.54

Adenosine A1 receptor antagonist improves intradialytic hypotension. Kidney Int (2006) 1.54

Preoperative visualization of the artery of Adamkiewicz by intra-arterial CT angiography. AJNR Am J Neuroradiol (2007) 1.54

Synergistic effects of different bone morphogenetic protein type I receptors on alkaline phosphatase induction. J Cell Sci (2001) 1.53

Obstructive jaundice promotes bacterial translocation from the gut. Am J Surg (1990) 1.52

An interesting case of rifampicin-dependent/-enhanced multidrug-resistant tuberculosis. Int J Tuberc Lung Dis (2010) 1.52

Characterization of MALS/Velis-1, -2, and -3: a family of mammalian LIN-7 homologs enriched at brain synapses in association with the postsynaptic density-95/NMDA receptor postsynaptic complex. J Neurosci (1999) 1.52

Stiff person syndrome: quantification, specificity, and intrathecal synthesis of GAD65 antibodies. Neurology (2001) 1.51

Amiodarone induces a different pattern of ultrastructural change in the thyroid to iodine excess alone in both the BB/W rat and the Wistar rat. Eur J Endocrinol (1997) 1.50

Dexmedetomidine provides cortical neuroprotection: impact on anaesthetic-induced neuroapoptosis in the rat developing brain. Acta Anaesthesiol Scand (2009) 1.50

TTF-1 and HNF-3beta in the developing tracheoesophageal fistula: further evidence for the respiratory origin of the distal esophagus'. J Pediatr Surg (1999) 1.50

Insulin-like growth factor binding protein 5 suppresses tumor growth and metastasis of human osteosarcoma. Oncogene (2011) 1.50